Harrow Inc. Common Stock (HROW)
Stock · NASDAQ · Health Care
$37.27as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$38.8
Industry
Biotechnology: Pharmaceutical Preparations
About HROW
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEV…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 373
- Website
- www.harrow.com/
Fundamentals
- 1-day range
- $37.07$38.8
- Market cap
- $1.46B
- P/E (trailing)
- —
- P/E (forward)
- 13.62
- EPS (trailing)
- $-1.00
- Dividend yield
- —
- Beta
- 0.14
- Avg. volume
- 662.4K
52-week range
$28.54$54.85
Next earnings: November 9, 2026 · EPS estimate $0.27confirmed
How Harrow Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
8 analyst ratings
Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$88
+136.1%
Median
$61.5
+65.0%
Low
$59
+58.3%
Harrow Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HROWHarrow Inc. Common Stock$37.23▼ 3.40%Market cap $1.46BP/E —$28.54$54.85
- XNCRXencor Inc. Common Stock$26.06▼ 9.76%Market cap $1.44BP/E —$7.8$30.61
- PAHCPhibro Animal Health Corporation Class A Common Stock$37.64▲ 3.55%Market cap $1.51BP/E 14.51$28.25$60.08
- INVAInnoviva Inc. Common Stock$20.97▲ 0.05%Market cap $1.53BP/E 4.21$16.52$25.15
- AVBPArriVent BioPharma Inc. Common Stock$30.19▼ 2.63%Market cap $1.38BP/E —$17$35.83
- AAPGAscentage Pharma Group International American Depository Shares$18.28▼ 2.16%Market cap $1.57BP/E —$30$91.5
- TRAXFirst Tracks Biotherapeutics Inc. Ordinary Shares$41.77▼ 6.64%Market cap $1.61BP/E —$14.72$49.91
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HROW Harrow Inc. Common Stock | $1.46B | — | $37.23 | ▼ 3.40% | $28.54$54.85 |
| XNCR Xencor Inc. Common Stock | $1.44B | — | $26.06 | ▼ 9.76% | $7.8$30.61 |
| PAHC Phibro Animal Health Corporation Class A Common Stock | $1.51B | 14.51 | $37.64 | ▲ 3.55% | $28.25$60.08 |
| INVA Innoviva Inc. Common Stock | $1.53B | 4.21 | $20.97 | ▲ 0.05% | $16.52$25.15 |
| AVBP ArriVent BioPharma Inc. Common Stock | $1.38B | — | $30.19 | ▼ 2.63% | $17$35.83 |
| AAPG Ascentage Pharma Group International American Depository Shares | $1.57B | — | $18.28 | ▼ 2.16% | $30$91.5 |
| TRAX First Tracks Biotherapeutics Inc. Ordinary Shares | $1.61B | — | $41.77 | ▼ 6.64% | $14.72$49.91 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 10 Health Care Stocks Whale Activity In Today’s SessionBenzinga · 8/25/2026
- Harrow’s Iheezo Cuts Eye-Injection Discomfort by More Than HalfBenzinga · 8/21/2026
- Harrow Reports Statistically Significant Results Favoring IHEEZO In Intravitreal Injection StudyBenzinga · 8/20/2026
- Harrow: The Q2 Turnaround Is Enough For A Cautious BuySeekingAlpha · 8/13/2026
- Harrow, Inc. (HROW) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/11/2026
- BTIG Reiterates Buy on Harrow, Maintains $63 Price TargetBenzinga · 8/11/2026
- OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · 8/11/2026
- Harrow Affirms FY2026 Sales Guidance of $350.000M-$365.000M vs $348.468M EstBenzinga · 8/10/2026
Insider Activity
Insider Actions →Acquired
41.2K
Disposed
198.6K
- Sternberg Perry J. · June 18, 2026 · Grant5.2K
- Adrienne L. Graves · June 18, 2026 · Grant5.2K
- Lauren P. Silvernail · June 18, 2026 · Grant5.2K
- Adrienne L. Graves · May 18, 2026 · Buy1.0K @ $31.07
- Lauren P. Silvernail · May 18, 2026 · Buy1.0K @ $31
- Shojaei Amir · May 15, 2026 · Grant10.0K
- Andrew R. Boll · May 14, 2026 · Buy3.5K @ $29.9
- Mark L. Baum · May 14, 2026 · Buy10.0K @ $30.2
- Opaleye Management Inc. · March 4, 2026 · Sale4.3K @ $39.67
- Opaleye Management Inc. · March 4, 2026 · Sale134.0K @ $39.67
- Opaleye Management Inc. · March 3, 2026 · Sale1.3K @ $39.15
- Opaleye Management Inc. · March 3, 2026 · Sale59.0K @ $39.15
Institutional Ownership
March 31, 2026
- Total shares held
- 22.44M
- Total value held
- $789.21M
- Institutional holders
- 213
Top holders this quarter
- Unknown2.83M
- Unknown2.55M
- Unknown1.60M
- Unknown1.47M
- Unknown1.40M
- Unknown1.12M
- Unknown855.0K
- Unknown852.0K
- Unknown644.9K
- Unknown579.5K
See the full, filterable feed with live charts on the MarketWall dashboard.